Literature DB >> 34000450

Oral 5-aminolevulinic acid administration prior to transurethral resection of bladder tumor causes intraoperative hypotension: Propensity score analysis.

Shohei Nakatani1, Mitsuru Ida2, Xiaoying Wang1, Yusuke Naito1, Masahiko Kawaguchi1.   

Abstract

BACKGROUND: Transurethral resection of bladder tumor (TUR-BT) using 5-aminolevulinic acid (5-ALA) is common; however, intraoperative hypotension is frequent. This study aimed to investigate the impact of preoperative oral 5-ALA taking on hypotension and vasopressors dose during general anesthesia, and postoperative nausea and vomiting.
METHODS: This retrospective study included patients aged ≥ 20 years who had undergone elective TUR-BT for bladder tumors under general anesthesia. An inverse probability of treatment weighted using stabilized inverse propensity scores was adopted to minimize bias. After adjustment based on patient data, outcomes of interest in patients with and without preoperative administration of 5-ALA were compared using a generalized estimating equation. Primary outcomes were hypotension incidence during anesthesia, which was defined as a mean arterial pressure < 60 mmHg, and the impact of 5-ALA administration on hypotension.
RESULTS: Of 324 patients considered, 153 (47.2%) received 5-ALA preoperatively. The weighted incidence of hypotension was 23.3% in patients taking 5-ALA, with an odds ratio of 4.21 (95% confidence interval 2.07-8.55). Odds ratios (ORs) and 95% confidence intervals for oral 5-ALA administration were 1.55 (1.23-1.96) for ephedrine, 1.18 (0.66-2.11) for phenylephrine, and 12.3 (5.73-26.5) for postoperative nausea and vomiting.
CONCLUSIONS: Preoperative oral 5-ALA administration was associated with hypotension during general anesthesia in patients who underwent TUR-BT despite receiving higher doses of ephedrine. Postoperative nausea and vomiting were also more common in these patients.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  5-aminolevulinic acid; Hypotension; Transurethral resection of bladder tumor

Year:  2021        PMID: 34000450     DOI: 10.1016/j.pdpdt.2021.102342

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  1 in total

Review 1.  Advances in Management of Bladder Cancer-The Role of Photodynamic Therapy.

Authors:  Tomasz Kubrak; Michał Karakuła; Marcin Czop; Aleksandra Kawczyk-Krupka; David Aebisher
Journal:  Molecules       Date:  2022-01-23       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.